Oracle's $638 Billion Gamble: Can Its Contract Backlog Outrun a Debt-Fueled Cash Burn?
Published on 09/02/2026 at 03:14 | Editorial boerse-global.de
The arithmetic at Oracle has become brutally simple. The company is pouring unprecedented sums into AI infrastructure while its cash flow runs deeply negative, and the bill is coming due at precisely the moment global bond markets are turning hostile. On Tuesday, shares closed at €121.74, down 5.1 percent on the day, leaving the stock roughly 59 percent below its September 2025 peak of €294.85. Year-to-date losses stand at about 27 percent, and the twelve-month decline has stretched to 37 percent.
The immediate trigger for Tuesday's slide was a fresh wave of layoff reports. Media outlets including Reuters indicated that Oracle is preparing to cut between 7,000 and 10,000 positions worldwide, with roughly 3,000 of those concentrated in India. Managers have reportedly been asked to identify roles for elimination, though the company has yet to confirm the scope or timing. Employees had earlier expected a wave of terminations around September 1, which did not materialize, leaving the schedule uncertain. The reports follow a fiscal 2026 in which headcount already fell by 21,000 to 141,000, with restructuring charges of $1.8 billion booked so far against a planned total of up to $2.1 billion.
The layoffs are widely read as an effort to protect operating margins while Oracle funnels billions into the data centers and chip capacity that its AI ambitions demand. That capital-intensive buildout has produced a striking financial profile. Total debt now stands at $218.7 billion, up from $147.4 billion, while equity sits at a comparatively thin $42.5 billion. During fiscal 2026 alone, Oracle took on $43 billion in new borrowings, with roughly $40 billion more planned. Capital expenditures have ballooned from $21.2 billion to $55.7 billion, driving free cash flow to negative $23.7 billion.
What makes the debt load particularly uncomfortable is the broader market context. A global selloff in bond markets has pushed ten-year US Treasury yields to levels not seen since January 2025, while thirty-year yields have reached their highest point in nearly two decades. For a company that must continuously refinance its obligations, rising rates translate directly into higher interest costs at the worst possible moment. The AI hyperscalers collectively have already issued $220 billion in bonds, more than double the prior year's volume, saturating a market that Oracle will need to tap again.
The bull case rests on a single, enormous number: the remaining performance obligations, or backlog, which has surged 363 percent in one year to $638 billion. That figure, proponents argue, demonstrates that the massive upfront spending on infrastructure is backed by contracted future cloud revenue. Citi's Tyler Radke maintains a Buy rating with a $330 price target, characterizing the recent selloff as panic-driven and noting that a decline of more than 50 percent within 30 to 40 days is statistically extreme. TD Cowen has trimmed its target to $240 but also holds a Buy rating, pointing to the backlog as a cushion. Oracle has beaten earnings expectations in each of the past two quarters, most recently by 7.65 percent, and a repeat performance at the upcoming report could steady the shares.
The operational momentum behind that optimism is real. Fiscal 2026 revenue rose 17 percent to $67.4 billion, with cloud revenue up 39 percent to $34 billion. Cloud infrastructure grew 77 percent, and the company guides to 58 to 64 percent growth in the coming quarter. For the first quarter of fiscal 2027, Oracle expects total revenue growth of 27 to 29 percent and adjusted earnings per share between $1.72 and $1.76. Management has guided to non-GAAP EPS of $8.05 for the full fiscal year, excluding one-time gains from investments in companies such as Ampere and Bloom Energy.
Yet the bearish counterargument is equally concrete. A free cash flow deficit of $23.7 billion means the expansion is being financed entirely through debt and capital markets issuance. Should cloud growth slip meaningfully below the guided 58 percent, or should refinancing costs climb further, the credibility of the entire leverage story would erode quickly.
While Oracle's restructuring highlights how quickly workforce and compliance landscapes can shift, UK employers face their own mounting obligations. Many businesses are unknowingly exposed to costly penalties because their risk assessments are outdated or incomplete. A free toolkit with 41 ready-to-use templates and checklists helps you document hazards and protect your workforce without hours of paperwork. Download the free Risk Assessment Toolkit
Regulatory risk adds another layer of uncertainty. The European Commission is gathering information on Oracle's licensing practices, a preliminary step reminiscent of the SAP case that was settled in July. While no formal investigation has been opened, that precedent suggests Oracle could face demands for concessions or fines of up to 10 percent of global revenue.
There are also smaller developments worth tracking. A $115 million privacy settlement has cleared its appeals process, with the payout window for affected parties reportedly set to begin September 21. On the product side, Oracle Health has expanded its Clinical AI Agent with enhanced documentation and coding features, now cleared for the US market.
Regulatory scrutiny isn't limited to tech giants — UK businesses face their own compliance pressures under the Health & Safety at Work Act. With enforcement tightening, having the right documentation is your first line of defence. A free toolkit provides 9 practical tools including risk assessments, checklists and a director's liability guide to help you stay compliant and protect your team. Get the free Health & Safety at Work Act Toolkit
The immediate technical picture offers little comfort. Tuesday's close left the stock hovering almost exactly at its 50-day moving average of €121.60, a level traders will watch closely in the sessions ahead. The next major catalyst arrives around September 10 or 11, when Oracle reports first-quarter results, followed by an investor day in late October. Those two events will show whether the company's AI wager is generating substance — or merely accumulating debt.
